{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:05:35Z","timestamp":1788807935767,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.molimm.2010.08.007","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T04:43:29Z","timestamp":1283402609000},"page":"219-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model"],"prefix":"10.1016","volume":"48","author":[{"given":"Sarah A.","family":"Ingersoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Barnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2010.08.007_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/JVI.73.1.205-213.1999","article-title":"Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates","volume":"73","author":"Albright","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0010","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.gt.3301197","article-title":"A simple method for the rapid generation of recombinant adenovirus vectors","volume":"7","author":"Anderson","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.molimm.2010.08.007_bib0015","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jnr.490270319","article-title":"Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules","volume":"27","author":"Armstrong","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(87)90055-4","article-title":"Blood-brain barrier permeability during cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases","volume":"78","author":"Bakker","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0030","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s11064-008-9792-8","article-title":"Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair","volume":"33","author":"Biancotti","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0035","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.4049\/jimmunol.173.7.4708","article-title":"Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis","volume":"173","author":"Boos","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2005.07.015","article-title":"C3a expressed in the central nervous system protects against LPS-induced shock","volume":"387","author":"Boos","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molimm.2010.08.007_bib0045","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/glia.20551","article-title":"Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model","volume":"55","author":"Briggs","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.molimm.2010.08.007_bib0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/glia.20328","article-title":"Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators","volume":"53","author":"Bsibsi","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.molimm.2010.08.007_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(02)00686-7","article-title":"Critical review of acylation-stimulating protein physiology in humans and rodents","volume":"1609","author":"Cianflone","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2010.08.007_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M","article-title":"Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells","volume":"26","author":"Davoust","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.molimm.2010.08.007_bib0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0165-5728(03)00009-2","article-title":"Regulation of chemokine receptor expression in human microglia and astrocytes","volume":"136","author":"Flynn","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0075","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1096\/fj.02-1103fje","article-title":"Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation","volume":"17","author":"Francis","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.molimm.2010.08.007_bib0080","first-page":"31","article-title":"Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system","volume":"150","author":"Gasque","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0085","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.4049\/jimmunol.160.7.3543","article-title":"The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis","volume":"160","author":"Gasque","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0090","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1471-4159.2004.02942.x","article-title":"Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties","volume":"92","author":"Gavrilyuk","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molimm.2010.08.007_bib0095","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.iy.12.040194.004015","article-title":"C5A anaphylatoxin and its seven transmembrane-segment receptor","volume":"12","author":"Gerard","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12311-009-0099-3","article-title":"Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum","volume":"8","author":"Groebe","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.molimm.2010.08.007_bib0105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02697367","article-title":"Anaphylatoxins: their role in bacterial infection and inflammation","volume":"37","author":"Haas","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1136(200003)30:1<1::AID-GLIA1>3.0.CO;2-Q","article-title":"TGFbeta1 selectively up-regulates CCR1 expression in primary murine astrocytes","volume":"30","author":"Han","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.molimm.2010.08.007_bib0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1471-4159.1998.70020699.x","article-title":"Inflammatory signals induce neurotrophin expression in human microglial cells","volume":"70","author":"Heese","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molimm.2010.08.007_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","article-title":"Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice","volume":"92","author":"Hiremath","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.2008.03830.x","article-title":"Complement in multiple sclerosis: its role in disease and potential as a biomarker","volume":"155","author":"Ingram","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0961203309348978","article-title":"C3aR inhibition reduces neurodegeneration in experimental lupus","volume":"19","author":"Jacob","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.molimm.2010.08.007_bib0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2010.02.011","article-title":"Inhibition of C5a receptor alleviates experimental CNS lupus","volume":"221","author":"Jacob","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00060-7","article-title":"Complement component anaphylatoxins upregulate chemokine expression by human astrocytes","volume":"537","author":"Jauneau","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molimm.2010.08.007_bib0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-3-8","article-title":"Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes","volume":"3","author":"Jauneau","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.molimm.2010.08.007_bib0155","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(87)90499-9","article-title":"Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice","volume":"425","author":"Kondo","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jnen\/63.5.499","article-title":"The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas","volume":"63","author":"Ligon","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nn.2491","article-title":"CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis","volume":"13","author":"Liu","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0175","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0180","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/glia.20646","article-title":"Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair","volume":"56","author":"Marriott","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.molimm.2010.08.007_bib0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","article-title":"Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination\/remyelination","volume":"61","author":"Mason","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0190","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","article-title":"Interleukin-1beta promotes repair of the CNS","volume":"21","author":"Mason","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0195","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1523\/JNEUROSCI.23-20-07710.2003","article-title":"Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination","volume":"23","author":"Mason","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0205","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1083\/jcb.85.3.890","article-title":"Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue","volume":"85","author":"McCarthy","year":"1980","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0210","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.4049\/jimmunol.167.5.2964","article-title":"Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier","volume":"167","author":"McMahon","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/mcne.1998.0715","article-title":"Gene expression in brain during cuprizone-induced demyelination and remyelination","volume":"12","author":"Morell","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-5-5","article-title":"Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo","volume":"5","author":"Mukherjee","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.molimm.2010.08.007_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-510X(96)00217-1","article-title":"Enhanced expression of chemotactic receptors in multiple sclerosis lesions","volume":"144","author":"Muller-Ladner","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0006-8993(01)02003-0","article-title":"Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage","volume":"894","author":"Nataf","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0235","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awn109","article-title":"Debris clearance by microglia: an essential link between degeneration and regeneration","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.molimm.2010.08.007_bib0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-5728(99)00117-4","article-title":"Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha","volume":"99","author":"Nikcevich","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0245","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0306-4522(96)00106-6","article-title":"Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton","volume":"73","author":"Nolte","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.molimm.2010.08.007_bib0250","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0306-4522(98)00372-8","article-title":"Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration","volume":"88","author":"Osaka","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.molimm.2010.08.007_bib0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2","article-title":"Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity","volume":"73","author":"Osaka","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molimm.2010.08.007_bib0260","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.4049\/jimmunol.181.5.3167","article-title":"Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes","volume":"181","author":"Qin","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0265","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.molimm.2010.08.007_bib0270","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2005.08.022","article-title":"Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis","volume":"390","author":"Reiman","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molimm.2010.08.007_bib0275","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/1521-4141(200204)32:4<1157::AID-IMMU1157>3.0.CO;2-M","article-title":"Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis","volume":"32","author":"Reiman","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0169-328X(03)00046-9","article-title":"Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes","volume":"112","author":"Sayah","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.molimm.2010.08.007_bib0285","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.225","article-title":"Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells","volume":"27","author":"Shinjyo","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.molimm.2010.08.007_bib0290","series-title":"Atlas of the Mouse Brain and Spinal Cord","author":"Sidman","year":"1971"},{"key":"10.1016\/j.molimm.2010.08.007_bib0295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2004.03.005","article-title":"Interferon-gamma produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes","volume":"151","author":"Stark","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"188","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.molimm.2010.08.007_bib0310","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.molimm.2010.08.007_bib0315","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The complement factor c5a contributes to pathology in a rat model of amyotrophic lateral sclerosis","volume":"181","author":"Woodruff","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.08.007_bib0320","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jnr.490270106","article-title":"Chemotaxis by a CNS macrophage, the microglia","volume":"27","author":"Yao","year":"1990","journal-title":"J. Neurosci. Res."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589010005511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589010005511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:24:26Z","timestamp":1758979466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589010005511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":64,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0161589010005511"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2010.08.007","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2010.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}